UBS maintains ArcBest at Neutral, lowers price target to $146 from $154
Moins d'1 minute de lecture
UBS maintained ArcBest at Neutral and lowered its price target to $146 from $154, a 5.2% decrease.
The price target implies an upside of 9.3% from the Nov 5 close of $133.59.
Recent analyst actions on ArcBest
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 5 | JP Morgan | Maintains | Neutral | $164 |
| Nov 5 | Citigroup | Maintains | Buy | $175 |
| Nov 5 | TD Cowen | Maintains | Hold | $146 |
| Oct 8 | Stifel | Maintains | Buy | $168 |
| Oct 7 | Truist Securities | Maintains | Buy | $160 |
Across the five most recent analyst notes published on ArcBest over the past 30 days, price targets range from $146 to $175.
Explore more price target data and ratings for ArcBest on the Forecasts tab, and track all previous and future analyst recommendations in the dedicated News Flow.
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.
Lire l'article complet
Obtenez un accès illimité aux mises à jour des analystes et à tous les autres articles sur TradingView.